Compartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment
Abstract Increasing cell‐specific productivities (CSPs) for the production of heterologous proteins in Chinese hamster ovary (CHO) cells is an omnipresent need in the biopharmaceutical industry. The novel additive 5′‐deoxy‐5′‐(methylthio)adenosine (MTA), a chemical degradation product of S‐(5′‐adeno...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley-VCH
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d171d3039cfe4829ada3ee91d61b3840 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d171d3039cfe4829ada3ee91d61b3840 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d171d3039cfe4829ada3ee91d61b38402021-12-02T13:20:01ZCompartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment1618-28631618-024010.1002/elsc.202100057https://doaj.org/article/d171d3039cfe4829ada3ee91d61b38402021-12-01T00:00:00Zhttps://doi.org/10.1002/elsc.202100057https://doaj.org/toc/1618-0240https://doaj.org/toc/1618-2863Abstract Increasing cell‐specific productivities (CSPs) for the production of heterologous proteins in Chinese hamster ovary (CHO) cells is an omnipresent need in the biopharmaceutical industry. The novel additive 5′‐deoxy‐5′‐(methylthio)adenosine (MTA), a chemical degradation product of S‐(5′‐adenosyl)‐ʟ‐methionine (SAM) and intermediate of polyamine biosynthesis, boosts the CSP of IgG1‐producing CHO cells by 50%. Compartment‐specific 13C flux analysis revealed a fundamental reprogramming of the central metabolism after MTA addition accompanied by cell‐cycle arrest and increased cell volumes. Carbon fluxes into the pentose‐phosphate pathway increased 22 fold in MTA‐treated cells compared to that in non‐MTA‐treated reference cells. Most likely, cytosolic ATP inhibition of phosphofructokinase mediated the carbon detour. Mitochondrial shuttle activity of the α‐ketoglurarate/malate antiporter (OGC) reversed, reducing cytosolic malate transport. In summary, NADPH supply in MTA‐treated cells improved three fold compared to that in non‐MTA‐treated cells, which can be regarded as a major factor for explaining the boosted CSPs.Andy Wiranata WijayaNatascha VerhagenAttila TelekiRalf TakorsWiley-VCHarticle13C MFAcell‐specific productivityCHOMTANADPHBiotechnologyTP248.13-248.65ENEngineering in Life Sciences, Vol 21, Iss 12, Pp 832-847 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
13C MFA cell‐specific productivity CHO MTA NADPH Biotechnology TP248.13-248.65 |
spellingShingle |
13C MFA cell‐specific productivity CHO MTA NADPH Biotechnology TP248.13-248.65 Andy Wiranata Wijaya Natascha Verhagen Attila Teleki Ralf Takors Compartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment |
description |
Abstract Increasing cell‐specific productivities (CSPs) for the production of heterologous proteins in Chinese hamster ovary (CHO) cells is an omnipresent need in the biopharmaceutical industry. The novel additive 5′‐deoxy‐5′‐(methylthio)adenosine (MTA), a chemical degradation product of S‐(5′‐adenosyl)‐ʟ‐methionine (SAM) and intermediate of polyamine biosynthesis, boosts the CSP of IgG1‐producing CHO cells by 50%. Compartment‐specific 13C flux analysis revealed a fundamental reprogramming of the central metabolism after MTA addition accompanied by cell‐cycle arrest and increased cell volumes. Carbon fluxes into the pentose‐phosphate pathway increased 22 fold in MTA‐treated cells compared to that in non‐MTA‐treated reference cells. Most likely, cytosolic ATP inhibition of phosphofructokinase mediated the carbon detour. Mitochondrial shuttle activity of the α‐ketoglurarate/malate antiporter (OGC) reversed, reducing cytosolic malate transport. In summary, NADPH supply in MTA‐treated cells improved three fold compared to that in non‐MTA‐treated cells, which can be regarded as a major factor for explaining the boosted CSPs. |
format |
article |
author |
Andy Wiranata Wijaya Natascha Verhagen Attila Teleki Ralf Takors |
author_facet |
Andy Wiranata Wijaya Natascha Verhagen Attila Teleki Ralf Takors |
author_sort |
Andy Wiranata Wijaya |
title |
Compartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment |
title_short |
Compartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment |
title_full |
Compartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment |
title_fullStr |
Compartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment |
title_full_unstemmed |
Compartment‐specific 13C metabolic flux analysis reveals boosted NADPH availability coinciding with increased cell‐specific productivity for IgG1 producing CHO cells after MTA treatment |
title_sort |
compartment‐specific 13c metabolic flux analysis reveals boosted nadph availability coinciding with increased cell‐specific productivity for igg1 producing cho cells after mta treatment |
publisher |
Wiley-VCH |
publishDate |
2021 |
url |
https://doaj.org/article/d171d3039cfe4829ada3ee91d61b3840 |
work_keys_str_mv |
AT andywiranatawijaya compartmentspecific13cmetabolicfluxanalysisrevealsboostednadphavailabilitycoincidingwithincreasedcellspecificproductivityforigg1producingchocellsaftermtatreatment AT nataschaverhagen compartmentspecific13cmetabolicfluxanalysisrevealsboostednadphavailabilitycoincidingwithincreasedcellspecificproductivityforigg1producingchocellsaftermtatreatment AT attilateleki compartmentspecific13cmetabolicfluxanalysisrevealsboostednadphavailabilitycoincidingwithincreasedcellspecificproductivityforigg1producingchocellsaftermtatreatment AT ralftakors compartmentspecific13cmetabolicfluxanalysisrevealsboostednadphavailabilitycoincidingwithincreasedcellspecificproductivityforigg1producingchocellsaftermtatreatment |
_version_ |
1718393297261559808 |